Ben Adams

Editor-in-Chief Ayla Ellison and Fierce Pharma Marketing Senior Editor Ben Adams discuss the most anticipated drug launches of 2024, including a schizophrenia drug awaiting FDA approval, Bristol Myers Squibb's targeted launch plan, and Madrigal Pharmaceuticals' goal to become a leader in liver health.

Fierce Biotech's Annalee Armstrong and Fierce Pharma's Ben Adams discuss the Best Biotech Name and Drug Names tournaments. They explore what makes a company or drug name impactful, the tournament results, and the winning names like Wainua, Werewolf, and Obsidian. The conversation touches on the importance of memorable, pronounceable, and distinct names in the biotech and drug industry.